Coronavirus infections in the Senate will likely delay confirmation of a Federal Trade Commission nominee who could break a tie vote that blocked an FTC probe of pharmacy benefit managers’ impact on drug prices. In a party-line, 2-2 vote, the Federal Trade Commission in February declined to undertake the inquiry into PBM business practices . Bedoya’s confirmation would tip the commission’s makeup in favor of Democratic appointees. “So believe me Democrats want to get Mr. Bedoya appointed as soon as...